Physical Fitness in Celiac Disease Patients - the Effect of a Gluten Free

Status Terminated

Clinical Trial Summary

Evaluating the effect of Celiac disease (CD) and gluten free diet (GFD) on physical fitness parameters among CD subjects. The CD subjects will be compared to healthy controls.

Clinical Trial Description

This is a prospective observational cohort study. The study would take place at Meir Medical Center (Kfar-Saba, Israel), a secondary-level academic hospital. The investigators will enroll 50 newly diagnosed CD subjects. The diagnosis will be in accordance with the European Society for Gastroenterology Hepatology and Nutrition guidelines for the diagnosis of CD from 2012 (6). The investigators will also enroll 50 control subjects. The control subjects are children visiting the pediatric gastroenterology clinic. Before enrollment the investigators will rule out chronic conditions involving the gastrointestinal tract including CD. All subjects will be enrolled after providing an informed consent and signing the consent form. The investigators will obtain the following measurements and evaluations at and 6 months after enrollment: 1. Anthropometric measurements: Height, weight, body mass index (BMI) and total body fat will be evaluated using a TANITA scale. The z-score for each parameter will be recorded. 2. A Godin leisure-time exercise questionnaire (7) will be filled by the subjects and their parents 3. Evaluation of physical fitness by the Eurofit fitness testing (8). This series of physical fitness tests was developed to evaluate speed, stamina and strength in school-aged children. 1. Flamingo balance test 2. Seat and reach test 3. Standing broad jump test 4. Handgrip test 5. Sit-ups test 6. Bent arm hang test 7. Twenty meter endurance shuttle run test 8. Wingate anaerobic fitness test 4. Bone speed of sound test will be performed by a bone sonometer - a non-invasive ultrasound based measurement of bone density. 5. CD subjects will be evaluated for adherence to GFD via questioning by a pediatric gastroenterologist and a clinical dietitian and by serum tissue transglutaminase immunoglobulin A (IgA) level (or serum deamidated gliadin peptide immunoglobulin G level in IgA deficient subjects). This is part of the normal follow-up of CD patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04012736
Study type	Observational
Source	Meir Medical Center
Contact
Status	Terminated
Phase
Start date	August 13, 2019
Completion date	April 5, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04440501` - Virtual Reality to Teach, Improve Outcomes, and Engage (VIRTUE): Virtual Reality to Improve Gluten-Free Diet Knowledge in Pediatric Celiac Disease	N/A
Enrolling by invitation	`NCT06179121` - "Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve Early Diagnosis of Celiac Disease"
Recruiting	`NCT06324539` - Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
Completed	`NCT06359613` - Efficacy Assessment of Gluten Free Cupcakes	N/A
Active, not recruiting	`NCT05548166` - Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease
Recruiting	`NCT04014660` - Prevention av Autoimmunitet Med Laktobaciller	N/A
Not yet recruiting	`NCT04019223` - Anti-Tissue Transglutaminase IgA Antibodies
Completed	`NCT03966625` - Serological Identification of Celiac Disease in Kids
Not yet recruiting	`NCT03244254` - Intestinal Fatty Acid-binding Protein (I-FABP) Levels in Pediatric Celiac Patients	N/A
Recruiting	`NCT05132725` - Carbohydrate Counting and DASH Intervention Among Children With Diabetes and Celiac Disease.	N/A
Enrolling by invitation	`NCT05084937` - Celiac Disease in Childhood-Adulthood Transition	N/A
Active, not recruiting	`NCT04593888` - Gluten Reduction and Risk of Celiac Disease	N/A
Recruiting	`NCT06007898` - Supporting Children and Young People to Live Well With Coeliac Disease	N/A
Recruiting	`NCT06364735` - Entities and Variables Related to Catch-up Growth
Completed	`NCT04272983` - Population Study of the Prevalence of Celiac Disease and Other Gluten-dependent Disorders in Children and Adolescents
Not yet recruiting	`NCT06149507` - Effect of Acetaminophen Versus Ibuprofen in Treating Recurrent Apthous Ulcers in Pediatric Celiac Disease	Phase 4
Completed	`NCT04240340` - Experiences of Disclosure in Adolescents With Coeliac Disease
Completed	`NCT03176095` - Celiac Disease Prevention With Probiotics	N/A
Active, not recruiting	`NCT06038344` - Influence of a Gluten Free Food Guide on Diet Quality and Adherence to the GFD in Youth With Celiac Disease	N/A
Completed	`NCT04533776` - Support for Adolescents With Celiac Disease	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Physical Fitness in Celiac Disease Patients - the Effect of a Gluten Free Diet

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms